Report copyright - J P Morgan Healthcare Conference - Glenmark …...Eli Lilly 2007 • Eli Lilly acquired the rights to a portfolio of TRPV1 antagonist molecules • Received an upfront fee of USD 45
Please pass captcha verification before submit form
Please pass captcha verification before submit form